By Lucia Osborne-Crowley ( August 6, 2021, 1:22 PM BST) -- U.S. drugmaker Tesaro has hit pharmaceutical giant AstraZeneca with a $3.6 million counterclaim in a dispute in England over licensing for a blockbuster cancer drug, saying it has paid too much in royalty fees to the Anglo-Swedish company....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.